# Body Weight Effects on Glucophage's Efficacy in Chinese Diagnosed T2DM Patients

> **NCT00778622** · PHASE4 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 371 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Metformin XR

## Key facts

- **NCT ID:** NCT00778622
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 371 (ACTUAL)
- **Last updated:** 2013-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00778622

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00778622, "Body Weight Effects on Glucophage's Efficacy in Chinese Diagnosed T2DM Patients". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00778622. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*